GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,254 | -31.5% | 7,454,703 | -0.5% | 0.00% | -33.3% |
| Q2 2023 | $41,219 | +25.4% | 7,494,184 | -2.0% | 0.01% | +20.0% |
| Q1 2023 | $32,871 | +15.2% | 7,644,195 | +5.3% | 0.01% | 0.0% |
| Q4 2022 | $28,536 | -99.9% | 7,261,046 | -1.8% | 0.01% | -16.7% |
| Q3 2022 | $39,272,000 | -33.0% | 7,395,573 | -17.2% | 0.01% | -14.3% |
| Q2 2022 | $58,591,000 | -8.9% | 8,931,613 | +1.9% | 0.01% | +16.7% |
| Q1 2022 | $64,325,000 | +5.1% | 8,763,691 | +1.3% | 0.01% | 0.0% |
| Q4 2021 | $61,222,000 | -71.7% | 8,647,121 | +0.2% | 0.01% | -70.0% |
| Q3 2021 | $216,309,000 | +9.2% | 8,628,216 | +17.2% | 0.02% | +11.1% |
| Q2 2021 | $198,068,000 | +7.3% | 7,363,115 | +13.5% | 0.02% | 0.0% |
| Q1 2021 | $184,550,000 | +48.1% | 6,484,544 | +47.6% | 0.02% | +38.5% |
| Q4 2020 | $124,575,000 | -3.3% | 4,394,184 | +1.7% | 0.01% | -13.3% |
| Q3 2020 | $128,866,000 | +52.3% | 4,320,962 | +3.3% | 0.02% | +36.4% |
| Q2 2020 | $84,615,000 | – | 4,181,178 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,279,484 | $31,379,244 | 4.86% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $3,875,415 | 0.71% |
| Artal Group S.A. | 2,814,191 | $10,666 | 0.46% |
| PFM Health Sciences, LP | 2,514,443 | $9,529,739 | 0.45% |
| Yiheng Capital Management, L.P. | 1,666,181 | $6,314,826 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 356,740 | $1,352,045 | 0.26% |
| EcoR1 Capital, LLC | 2,046,867 | $7,757,626 | 0.26% |
| Bellevue Group AG | 3,617,080 | $13,708,733 | 0.22% |
| SVB FINANCIAL GROUP | 25,034 | $94,879 | 0.18% |
| CORNERCAP INVESTMENT COUNSEL INC | 37,681 | $142,811 | 0.03% |